Retrospective Analyses of TrakStar Database

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-120
SponsorNeuronetics

About this trial

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Eligibility criteria

Qualifiers

Male or female reported in database and not an invalid entry

Age reported and not an invalid entry

Treatment date of November 01, 2008 or later.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • NeuroStar Advanced TMS Therapy System

Treatment groups

156,000 Participants
are divided into 1 treatment group

Sponsors and collaborators